Multicenter Experience with FRED Jr Flow Re-Direction Endoluminal Device for Intracranial Aneurysms in Small Arteries

The authors assessed the clinical safety and efficacy of the Flow Re-Direction Endoluminal Device Jr (FRED Jr) dedicated to small-vessel diameters between 2.0 and 3.0 mm in 42 patients with 47 aneurysms. The primary efficacy end point of complete or near complete occlusion was reached at 1 month in 27/41 (66%), at 6 months in 21/27 (78%), and at 12 months in 11/11 (100%) aneurysms. BACKGROUND AND PURPOSE: Flow diverters are emerging as an endovascular treatment alternative for proximally located intracranial aneurysms. However, treatment of aneurysms at and beyond the circle of Willis is not well-established. We assessed the clinical safety and efficacy of the Flow Re-Direction Endoluminal Device Jr (FRED Jr) dedicated to small-vessel diameters between 2.0 and 3.0 mm. MATERIALS AND METHODS: This was a multicenter observational clinical study of 42 patients with 47 aneurysms treated by a flow-direction technique with the FRED Jr. The primary end point for clinical safety was the absence of death, major or minor stroke, and TIA. The primary end point for treatment efficacy was complete and near-complete occlusion according to the O'Kelly-Marotta grading scale at follow-up after 1, 6, and 12 months. RESULTS: The FRED Jr deployment was technically successful in all cases. In 39/42 (93%) patients, the primary safety end point was reached; in the 3 remaining patients, 1 disabling ischemic stroke, 1 minor stroke with complete recovery at discharge, and 1 TIA were observed. Two asymptomatic, completely reversible side-branch occlusions occurred. Angiographic (DSA or flat panel CT) and clinical follow-up were available after 1 month in 41/47 (87%), 6 months in 27/47 (57%), and 12 months in 11/47 (23%) aneurysms. The primary efficacy end point was reached at 1 month in 27/41 (66%), at 6 months in 21/27 (78%), and at 12 months in 11/11 (100%) aneurysms. CONCLUSIONS: Deployment of the FRED Jr is safe and effective in the treatment of intracranial aneurysms located in small vessels.

[1]  A. Doerfler,et al.  FRED Flow Diverter: A Study on Safety and Efficacy in a Consecutive Group of 50 Patients , 2017, American Journal of Neuroradiology.

[2]  S. Rohde,et al.  Treatment of Intra- and Extracranial Aneurysms Using the Flow-Redirection Endoluminal Device: Multicenter Experience and Follow-Up Results , 2017, American Journal of Neuroradiology.

[3]  A. Siddiqui,et al.  Risk Factors for Ischemic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the IntrePED Study , 2016, American Journal of Neuroradiology.

[4]  Vittoria Flamini,et al.  A numerical framework for the mechanical analysis of dual-layer stents in intracranial aneurysm treatment. , 2016, Journal of biomechanics.

[5]  C. Ogilvy,et al.  Treatment of Distal Anterior Circulation Aneurysms With the Pipeline Embolization Device: A US Multicenter Experience. , 2016, Neurosurgery.

[6]  D. Solari,et al.  Safety and efficacy of flow re-direction endoluminal device (FRED) in the treatment of cerebral aneurysms: a single center experience , 2016, Acta Neurochirurgica.

[7]  A. Siddiqui,et al.  The Use of Flow Diversion for the Treatment of Intracranial Aneurysms: Expansion of Indications , 2016, Cureus.

[8]  N. Kocer.  Giant Intracranial Aneurysms , 2016 .

[9]  A. Wakhloo,et al.  Safety, efficacy, and short-term follow-up of the use of Pipeline™ Embolization Device in small (<2.5mm) cerebral vessels for aneurysm treatment: single institution experience , 2016, Neuroradiology.

[10]  P. Ringleb,et al.  The FRED Flow-Diverter Stent for Intracranial Aneurysms: Clinical Study to Assess Safety and Efficacy , 2015, American Journal of Neuroradiology.

[11]  F. Bonneville,et al.  Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries , 2015, Journal of NeuroInterventional Surgery.

[12]  C. O’Kelly,et al.  Small Pipes: Preliminary Experience with 3-mm or Smaller Pipeline Flow-Diverting Stents for Aneurysm Repair prior to Regulatory Approval , 2015, American Journal of Neuroradiology.

[13]  T. Krings,et al.  Enhancing Brain Lesions after Endovascular Treatment of Aneurysms , 2014, American Journal of Neuroradiology.

[14]  F. Mut,et al.  Analysis of Hemodynamics and Aneurysm Occlusion after Flow-Diverting Treatment in Rabbit Models , 2014, American Journal of Neuroradiology.

[15]  G. Dabus,et al.  Pipeline endovascular device for the treatment of intracranial aneurysms at the level of the circle of Willis and beyond: multicenter experience , 2014, Journal of NeuroInterventional Surgery.

[16]  N. Kocer,et al.  Flow Re-direction Endoluminal Device in treatment of cerebral aneurysms: initial experience with short-term follow-up results. , 2014, Journal of neurosurgery.

[17]  David F. Kallmes,et al.  Endovascular Treatment of Intracranial Aneurysms With Flow Diverters: A Meta-Analysis , 2013, Stroke.

[18]  R. Blanc,et al.  Flow Diverters at and Beyond the Level of the Circle of Willis for the Treatment of Intracranial Aneurysms , 2012, Stroke.

[19]  J. Pruvo,et al.  Flow-Diverter Stent for the Endovascular Treatment of Intracranial Aneurysms: A Prospective Study in 29 Patients With 34 Aneurysms , 2010, Stroke.

[20]  T. Krings,et al.  A Novel Grading Scale for the Angiographic Assessment of Intracranial Aneurysms Treated Using Flow Diverting Stents , 2010, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[21]  D F Kallmes,et al.  A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms , 2009, American Journal of Neuroradiology.

[22]  J. Lamoureux,et al.  Long-Term Angiographic Recurrences After Selective Endovascular Treatment of Aneurysms With Detachable Coils , 2003, Stroke.